company
as of 2026-07-01Hoffmann-La Roche
at a glance
20 trials sponsored · 12 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
12 assets
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Bitopertin
drugsmall molecule
Olanzapine
drugsmall molecule
Risperidone
drugsmall molecule
Antipsychotics
drugsmall molecule
Basmisanil
drugsmall molecule
MEM 3454
drugsmall molecule
RO4917838
drugsmall molecule
RO5545965
drugsmall molecule